Gobbi C, et al. Real-world data from the TACO (teriflunomide in relapsing remitting multiple sclerosis patients assessing clinical benefit and patient-reported outcomes) study. Poster 1371. ECTRIMS 2019, 11-13 sept 2019, Stockholm, Zweden.
Lixisenatide bij vroege Parkinson: minder progressie van motorische beperkingen
jun 2024 | Bewegingsstoornissen